Skip to main content
construction release_alert
Scholars@Duke will be undergoing maintenance April 11-15. Some features may be unavailable during this time.
cancel
Journal cover image

Passive immunization with polyclonal anti-SHIV IgG: partial protection or increased acquisition of heterologous tier 2 SHIV - depending on IgG dose

Publication ,  Conference
Sholukh, AM; Siddappa, NB; Shanmuganathan, V; Lakhashe, SK; Rasmussen, RA; Watkins, JD; Vyas, HK; Mukhtar, MM; Hemashettar, G; Thorat, S ...
Published in: RETROVIROLOGY
September 13, 2012

Duke Scholars

Published In

RETROVIROLOGY

ISSN

1742-4690

Publication Date

September 13, 2012

Volume

9

Publisher

BIOMED CENTRAL LTD

Related Subject Headings

  • Virology
  • 3107 Microbiology
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Sholukh, A. M., Siddappa, N. B., Shanmuganathan, V., Lakhashe, S. K., Rasmussen, R. A., Watkins, J. D., … Ruprecht, R. M. (2012). Passive immunization with polyclonal anti-SHIV IgG: partial protection or increased acquisition of heterologous tier 2 SHIV - depending on IgG dose. In RETROVIROLOGY (Vol. 9). BIOMED CENTRAL LTD.
Sholukh, A. M., N. B. Siddappa, V. Shanmuganathan, S. K. Lakhashe, R. A. Rasmussen, J. D. Watkins, H. K. Vyas, et al. “Passive immunization with polyclonal anti-SHIV IgG: partial protection or increased acquisition of heterologous tier 2 SHIV - depending on IgG dose.” In RETROVIROLOGY, Vol. 9. BIOMED CENTRAL LTD, 2012.
Sholukh AM, Siddappa NB, Shanmuganathan V, Lakhashe SK, Rasmussen RA, Watkins JD, et al. Passive immunization with polyclonal anti-SHIV IgG: partial protection or increased acquisition of heterologous tier 2 SHIV - depending on IgG dose. In: RETROVIROLOGY. BIOMED CENTRAL LTD; 2012.
Sholukh AM, Siddappa NB, Shanmuganathan V, Lakhashe SK, Rasmussen RA, Watkins JD, Vyas HK, Mukhtar MM, Hemashettar G, Thorat S, Yoon JK, Villinger F, Novembre FJ, Landucci G, Forthal DN, Ratcliffe S, Robert-Guroff M, Polonis V, Montefiori DC, Ertl HC, Ruprecht RM. Passive immunization with polyclonal anti-SHIV IgG: partial protection or increased acquisition of heterologous tier 2 SHIV - depending on IgG dose. RETROVIROLOGY. BIOMED CENTRAL LTD; 2012.
Journal cover image

Published In

RETROVIROLOGY

ISSN

1742-4690

Publication Date

September 13, 2012

Volume

9

Publisher

BIOMED CENTRAL LTD

Related Subject Headings

  • Virology
  • 3107 Microbiology
  • 1103 Clinical Sciences